Cambridge Investment Research Advisors, Inc. Agenus Inc Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$0.53 - $0.93 $2,136 - $3,749	-4,032 Reduced 14.2%	24,371 $14,000
Q4 2023 Feb 09, 2024	SELL	$0.63 - $1.14 $2,173 - $3,932	-3,450 Reduced 10.83%	28,403 $24,000
Q3 2023 Oct 24, 2023	BUY	$1.12 - $1.88 $10,361 - $17,391	9,251 Added 40.93%	31,853 $36,000
Q2 2023 Jul 13, 2023	SELL	$1.31 - $2.04 $2,423 - $3,774	-1,850 Reduced 7.57%	22,602 $36,000
Q1 2023 May 11, 2023	BUY	$1.45 - $2.95 $1,885 - $3,835	1,300 Added 5.62%	24,452 $37,000
Q4 2022 Feb 08, 2023	SELL	$2.02 - $3.25 $4,545 - $7,312	-2,250 Reduced 8.86%	23,152 $56,000
Q3 2022 Oct 17, 2022	SELL	$1.96 - $3.14 $3,136 - $5,024	-1,600 Reduced 5.93%	25,402 $52,000
Q1 2022 May 12, 2022	SELL	$2.35 - $3.47 $44,180 - $65,236	-18,800 Reduced 41.05%	27,002 $66,000
Q4 2021 Feb 03, 2022	BUY	$2.92 - $5.74 $8,614 - $16,933	2,950 Added 6.88%	45,802 $147,000
Q3 2021 Nov 02, 2021	BUY	$4.98 - $6.63 $32,370 - $43,095	6,500 Added 17.88%	42,852 $224,000
Q2 2021 Aug 10, 2021	BUY	$2.56 - $5.49 $46,387 - $99,478	18,120 Added 99.39%	36,352 $199,000
Q1 2021 May 07, 2021	BUY	$2.69 - $5.25 $215 - $420	80 Added 0.44%	18,232 $49,000
Q4 2020 Feb 04, 2021	SELL	$3.17 - $4.49 $2,377 - $3,367	-750 Reduced 3.97%	18,152 $57,000
Q3 2020 Oct 29, 2020	BUY	$2.98 - $5.2 $15,147 - $26,431	5,083 Added 36.78%	18,902 $75,000
Q1 2020 May 08, 2020	SELL	$1.92 - $4.39 $960 - $2,195	-500 Reduced 3.49%	13,819 $33,000
Q4 2019 Feb 04, 2020	BUY	$2.41 - $4.4 $2,169 - $3,960	900 Added 6.71%	14,319 $58,000
Q2 2019 Aug 15, 2019	BUY	$2.53 - $3.04 $33,950 - $40,793	13,419 New	13,419 $0
Q4 2018 Feb 05, 2019	SELL	$1.59 - $2.66 $18,021 - $30,148	-11,334 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$1.59 - $2.42 $18,021 - $27,428	11,334 New	11,334 $0

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account